TITLE

Basal metabolic rate in morbidly obese patients with non-alcoholic fatty liver disease

AUTHOR(S)
Tarantino, Giovanni; Marra, Maurizio; Contaldo, Franco; Pasanisi, Fabrizio
PUB. DATE
February 2008
SOURCE
Clinical & Investigative Medicine;Feb2008, Vol. 31 Issue 1, pE24
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background. Non-Alcoholic Fatty Liver Disease occurs mainly in severly obese patients and its relationship to Metabolic Syndrome is increasingly recognized. The aim of this study was to determine energy productionutilization by measuring the Basal Metabolic Rate in severely obese patients, characterized by NAFLD, with or without Metabolic Syndrome. Then, the role of systemic inflammation was assessed. Patients and methods. Twenty severly obese men with Metabolic Syndrome were compared with a well-matched cohort of patients without Metabolic Syndrome. All showed hepatic steatosis at UltraSonography. Basal Metabolic Rate was measured by indirect calorimetry using a canopy system and single-frequency bio-impedance analysis. Serum Interleukin-6 and fibrinogen levels were measured as markers of inflammation Results. Basal Metabolic Rate was higher in severely obese patients with Metabolic Syndrome than in those without it: 2,496±358 kcal/d vs 2,126±253 kcal/d, P = 0 .001. Laboratory findings of concurrent chronic inflammation were also higher in these patients, i.e., Il6 4.35±1.34 pg/ml vs 6.23±2.1 pg/ml, P = 0.034; fibrinogenemia 285±40 mg/dL vs 376±91 mg/dL, P = 0.020; these of of cytonecrosis, i.e., AlaninaminoTransferase, equally behaved 32.3±7.9 UI vs 65.7±28.2 UI, P < 0.001. Visceral adiposity and arterial hypertension were more frequently detected in patients with Metabolic Syndrome. Conclusion. Increased energy expenditure, observed in morbidly obese patients as a consequence of a systemic, low-grade, inflammatory process, may explain progression from obesity to Metabolic Syndrome, independent of the presence of NAFLD. In this context, increased Basal Metabolic Rate may be a clue of Metabolic Syndrome.
ACCESSION #
31198405

 

Related Articles

  • What Non-Alcoholic Fatty Liver Disease Has Got to Do with Obstructive Sleep Apnoea Syndrome and viceversa? Tarantino, Giovanni; Citro, Vincenzo; Finelli, Carmine // Journal of Gastrointestinal & Liver Diseases;Sep2014, Vol. 23 Issue 3, p291 

    Non-alcoholic fatty liver disease (NAFLD) and obstructive sleep apnoea syndrome (OSAS) are common conditions, frequently encountered in patients with obesity and/or metabolic syndrome. NAFLD and OSAS are complex diseases that involve an interaction of several intertwined factors. Several lines...

  • Multidisciplinary Approach to the Treatment of Obese Adolescents: Effects on Cardiovascular Risk Factors, Inflammatory Profile, and Neuroendocrine Regulation of Energy Balance. Dâmaso, Ana Raimunda; Piano, Aline de; Silveira Campos, Raquel Munhoz da; Corgosinho, Flávia Campos; Siegfried, Wolfgang; Caranti, Danielle Arisa; LandiMasquio, Deborah Cristina; Carnier, June; de Lima Sanches, Priscila; Silva, Patrícia Leão da; Oller Nascimento, CláudiaMaria; Oyama, Lila Missae; Dâmaso Aguilera Dantas, Alexandre; Tùlio de Mello, Marco; Tufik, Sergio; Tock, Lian // International Journal of Endocrinology;2013, p1 

    The prevention of obesity and health concerns related to body fat is a major challenge worldwide. The aim of this study was to investigate the role of a medically supervised, multidisciplinary approach, on reduction in the prevalence of obesity related comorbidities, inflammatory profile, and...

  • Can ESR be used to assess the levels of oxidative stress in fat-loaded human hepatocytes and hepatic stellate cells? Wetherill, Laura Faye // Bioscience Horizons: The National Undergraduate Research Journal;Jun2009, Vol. 2 Issue 2, p197 

    Non-alcoholic fatty liver disease (NAFLD) is a growing clinical problem, which manifests itself particularly in obese subjects who may have the metabolic syndrome. A two-hit hypothesis for the pathogenesis of the disease has been proposed. The first hit is the development of insulin resistance...

  • Intra-abdominal fat is related to metabolic syndrome and non-alcoholic fat liver disease in obese youth. Sanches Silveira, Loreana; Alves Monteiro, Paula; de Moura Mello Antunes, Bárbara; Monteiro Seraphim, Patrícia; Araújo Fernandes, Rômulo; Destro Christofaro, Diego G.; Freitas Júnior, Ismael F. // BMC Pediatrics;2013, Vol. 13 Issue 1, p1 

    Background: Previous studies have shown an association between adiposity, especially intra-abdominal adipose tissue, and hemodynamic/metabolic comorbidities in adults, however it is not clear in pediatric population. The aim of the study was to analyze the relationship between non-alcoholic...

  • Caffeine Consumption Prevents Diabetes-Induced Memory Impairment and Synaptotoxicity in the Hippocampus of NONcZNO10/LTJ Mice. Duarte, João M. N.; Agostinho, Paula M.; Carvalho, Rui A.; Cunha, Rodrigo A. // PLoS ONE;Apr2012, Vol. 7 Issue 4, p1 

    Diabetic conditions are associated with modified brain function, namely with cognitive deficits, through largely undetermined processes. More than understanding the underlying mechanism, it is important to devise novel strategies to alleviate diabetes-induced cognitive deficits. Caffeine (a...

  • Cut-off values of waist circumference to predict metabolic syndrome in obese adolescents. Landi Masquio, Deborah Cristina; de Piano Ganen, Aline; da Silveira Campos, Raquel Munhoz; de Lima Sanches, Priscila; Campos Corgosinho, Flávia; Caranti, Danielle; Tock, Lian; Túlio de Mello, Marco; Tufik, Sergio; Dâmaso, Ana R. // Nutricion Hospitalaria;abr2015, Vol. 31 Issue 4, p1540 

    Introduction: Metabolic syndrome (MetS) is a constellation of metabolic alterations related to abdominal obesity, inflammation and insulin resistance, which increase cardiovascular disease and mortality. The aims of the present study were to identify the prevalence of comorbidities and altered...

  • Sinusoidal Endothelial Dysfunction Precedes Inflammation and Fibrosis in a Model of NAFLD. Pasarín, Marcos; La Mura, Vincenzo; Gracia-Sancho, Jorge; García-Calderó, Hé ctor; Rodríguez-Vilarrupla, Aina; García-Pagán, Juan Carlos; Bosch, Jaime; Abraldes, Juan G. // PLoS ONE;Apr2012, Vol. 7 Issue 4, p1 

    Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of the metabolic syndrome. Most morbidity associated with the metabolic syndrome is related to vascular complications, in which endothelial dysfunction is a major pathogenic factor. However, whether NAFLD is associated with...

  • INFLAMMATION AND CARDIOVASCULAR RISK ASSESSMENT IN MOROCCAN OBESE PATIENTS WITH AND WITHOUT METABOLIC SYNDROME: IMPORTANCE OF LIPOPROTEINS RATIOS. Essiarab, Fadwa; Hassan Taki; Lebrazi, Halima; Derouiche, Abdelfettah; Kettani, Anass; Sabri, Maati; Saïle, Rachid // Ethnicity & Disease;Autumn2014, Vol. 24 Issue 4, p462 

    Background: Obesity predisposes an individual to numerous risk factors for cardiovascular diseases, inflammation, reported as a link between obesity and cardiovascular disease, contributes to the development of atherosclerosis. Objectives: The aim of our study was to assess the relationship...

  • Correlation between liver fat content with dyslipidemia and Insulin resistance. Saran, Sanjay; Philip, Rajeev; Gutch, Manish; Tyagi, Rajeev; Agroiya, Puspalata; Gupta, Keshav Kumar // Indian Journal of Endocrinology & Metabolism;2013 Supplement, Vol. 17 Issue S1, pS355 

    Total 33 obese patients were studied to determine correlation in between liver fat content with dyslipidemia and insulin resistance. Liver and spleen attenuation measurements were taken with three regions of interests (ROIs) from the liver and two ROIs from the spleen. Hepatic attenuation...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics